Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

NCT03479372 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG: PAN-90806 Ophthalmic Suspension

Sponsor

PanOptica, Inc.